In a study published in Nature, researchers led by Prof. Hu Zheng from the Shenzhen Institutes of Advanced Technology (SIAT) ...

Fructose, the most common food sweetener, is widely used in processed sugary beverages, candies, and baked goods. Excessive ...

The most important takeaway from the study is that these data suggest that CD47 is an attractive target for drug development.

Investigation shows how bacterial adhesins contribute to colon cancer mutations, suggesting new avenues for therapeutic ...

EXCLUSIVE - When Richard Nelson had his shock bowel cancer diagnosis he was offered a new innovative 'vaccine' clinical trial ...

For example, a 2022 review in Cancer Medicine suggests too much iron can increase the risk of lung and colorectal cancers, ...

However, recurrence following surgery is a major problem and is often the ultimate cause of death. Colorectal cancer can ...

part of the Keck School of Medicine of USC The researchers knew colorectal cancer cells use the immune checkpoint CD47 to dodge macrophages, innate immune cells that would otherwise target and destroy ...

The trial will enrol patients with mCRC who are microsatellite stable (MSS), wild type (WT) RAS, WT BRAF, and human epidermal ...

A new USC study has found evidence that targeting CD47, a protein that is part of the innate immune system, could be a key step in fighting colorectal cancer. It is one of the first indications that ...

Metabolic enzymes, typically associated with energy production, are now discovered to also play essential roles in the nucleus, such as orchestrating cell division and DNA repair. This breakthrough, ...